COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that ...
Novo raced to meet demand for its weight-loss drug Wegovy Workforce almost doubled in five years Rapid expansion now under scrutiny amid cost pressure After profit warning, new CEO is looking for cost ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback